TickerFacts.

Anika Therapeutics, Inc. (ANIK): Gross Profit

Annual figures by period end, from SEC filings. For years the company left out, it is revenue minus cost of revenue, computed by TickerFacts; where both exist they agree (see each figure's source).

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$63.81M
Year ended 2025-12-31
$75.00M
Trailing 12 months to 2026-06-30
-4.5%
3-year compound annual growth
$86.06M2009-12-31: $26.47M2010-12-31: $31.73M2011-12-31: $37.99M2012-12-31: $42.37M2013-12-31: $52.32M2014-12-31: $84.67M2015-12-31: $71.95M2016-12-31: $79.35M2017-12-31: $86.06M2018-12-31: $74.28M2019-12-31: $85.86M2020-12-31: $69.03M2021-12-31: $82.94M2022-12-31: $73.22M2023-12-31: $82.53M2024-12-31: $76.00M2025-12-31: $63.81M$63.81M
2009-12-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$63.81M-16.0%2026-03-03, From 2025-01-01
2024-12-31$76.00M-7.9%2026-03-03, From 2024-01-01
2023-12-31$82.53M+12.7%2026-03-03, From 2023-01-01
2022-12-31$73.22Mn/c2025-03-17, From 2022-01-01
2021-12-31$82.94M+20.2%2024-03-15, From 2021-01-01
2020-12-31$69.03M-19.6%2023-03-16, From 2020-01-01
2019-12-31$85.86M+15.6%2022-03-11, From 2019-01-01
2018-12-31$74.28M-13.7%2021-04-26, From 2018-01-01
2017-12-31$86.06M+8.4%2020-03-06, From 2017-01-01
2016-12-31$79.35M+10.3%2019-02-27, From 2016-01-01
2015-12-31$71.95M-15.0%2018-02-27, From 2015-01-01
2014-12-31$84.67M+61.8%2017-02-24, From 2014-01-01
2013-12-31$52.32M+23.5%2016-03-10, From 2013-01-01
2012-12-31$42.37M+11.5%2015-03-13, From 2012-01-01
2011-12-31$37.99M+19.7%2014-03-13, From 2011-01-01
2010-12-31$31.73M+19.9%2013-03-14, From 2010-01-01
2009-12-31$26.47Mn/a2012-03-13, From 2009-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
Anika Therapeutics, Inc. (ANIK)2025-12-31$63.81M-16.0%
Orasure Technologies Inc (OSUR)2025-12-31$48.20M-39.3%
Beta Bionics, Inc. (BBNX)2025-12-31$55.54M+54.8%
NeuroPace Inc (NPCE)2025-12-31$77.22M+30.7%
Kestra Medical Technologies, Ltd. (KMTS)2026-04-30$48.86M+101.8%
Xtant Medical Holdings, Inc. (XTNT)2025-12-31$84.27M+23.5%
Pulmonx Corp (LUNG)2025-12-31$67.14M+8.3%
InfuSystem Holdings, Inc (INFU)2025-12-31$80.30M+14.1%
Neuronetics, Inc. (STIM)2025-12-31$72.31M+33.5%

Compare ANIK, OSUR, BBNX, NPCE side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗